Table 3.
Characteristics of the Study Subjects Before and After Propensity Score Matching
| Characteristics | Before Matching | After Matching | ||||
|---|---|---|---|---|---|---|
| AEAT Group (n=29) | IEAT Group (n=65) | P | AEAT Group (n=29) | IEAT Group (n=29) | P | |
| SOFA | 9.14±3.22 | 6.66±3.78 | 0.003 | 9.14±3.22 | 8.48±3.75 | 0.478 |
| PLT (*109/L) | 90.0(45.0–195.0) | 184.0(114.3–275.3) | 0.000 | 90.0(45.0–195.0) | 137.0(70.0–178.5) | 0.388 |
| PCT (ng/mL) | 2.0(0.9–10.7) | 0.7(0.3–2.2) | 0.004 | 2.0(0.9–10.7) | 2.0(0.5–6.5) | 0.347 |
| LAC (mmol/L) | 1.6(1.2–2.2) | 1.1(0.8–1.8) | 0.029 | 1.6(1.2–2.2) | 1.7(0.9–2.2) | 0.919 |
| ICU mortality, n (%) | 8(27.6) | 16(24.6) | 0.760 | 8(27.6) | 12(41.4) | 0.269 |
| 28-day mortality, n (%) | 18(62.1) | 25(38.5) | 0.036 | 18(62.1) | 16(55.2) | 0.594 |
Abbreviations: AEAT, appropriate empirical antibiotic treatment; IEAT, inappropriate empirical antibiotic treatment; SOFA, sequential organ failure assessment; PLT, platelet; PCT, procalcitonin; LAC, lactic acid; ICU, intensive care unit.